Recent clinical research highlights findings across sexual health, chronic disease management, and pharmaceutical developments.

New data suggests that prescribing Doxycycline effectively reduces the risk of recurrent rectal chlamydia among men who have sex with men.

Researchers have identified a potential link between mild hand tremors in older adults and an increased risk of cognitive decline.

Studies show that while cannabis use initially appears to increase fall risks for adults with HIV, the correlation diminishes when adjusting for other medications and substance use.

The ongoing Ebola outbreak in the Democratic Republic of Congo has become the second-most lethal on record, following the historic West African epidemic.

A recent meta-analysis indicates no significant association between the use of the weight-loss drug semaglutide and the development of depression.

AstraZeneca has officially terminated a late-stage clinical trial for its experimental lung cancer treatment, Volrustomig.

One year post-approval for rheumatoid arthritis, Vagus Nerve Stimulation (VNS) devices face slow adoption due to widespread hesitation from insurance providers.

Severe obesity (Class III) is identified as a major mortality risk factor for younger adults, whereas its impact on mortality is less pronounced in older age groups.